Dr. Stefania Marcuzzo obtained her BS in Biological Science at University of Milan (Milan) Dept. of Pharmacology, Chemotherapy and Medical Toxicology, Behavioral Unit, in 2005. In 2008, she obtained her MSc in Neurobiology at University of Pavia (Pavia), Dept. of Molecular, Cellular, Pharmacological and Physiological Science.

In 2009, she joined the Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico Carlo Besta (FINCB), with a fellowship on projects aimed at investigating amyotrophic lateral sclerosis (ALS) pathogenesis in the G93A-SOD1 animal model.

In January 2013, Dr. Marcuzzo obtained her PhD degree in Translational and Molecular Medicine (DIMET) at University of Milano Bicocca (Milan).

Dr. Marcuzzo is a post-doctoral researcher investigator at the Neurology IV Unit, FINCB. She has been actively involved in research projects aimed at investigating the molecular mechanisms underlying the pathogenesis of motor neuron diseases, focusing on the study of ALS. At FINCB, she has always participated in the design of the experimental plan of the different projects on ALS, carrying out and coordinating the experimental activities of PhD students, junior fellowship and students.

She is authors of research articles whose results were important for deepening molecular basis of ALS pathogenesis, and particularly for deciphering the role of microRNAs in the disease.